Prostate cancer is the second most common cancer in men, and almost 300,000 individuals are diagnosed with it each year in the U.S. To develop a consistent method of estimating prostate cancer size, ...
Prostate Volume Assist (PVA) is the company’s proprietary urology-based artificial intelligence (AI) software feature designed to automate the manual process for generating prostate volume ...
GE HealthCare Technologies Inc. GEHC recently announced the launch of the Prostate Volume Assist (PVA) urology-based artificial intelligence (AI) software feature. This AI-powered software function ...
Sarah Leverett, Vice President of Marketing at Clarius, highlights the time-saving potential of AI for physicians facing high demand: "95% of clinicians we recently surveyed believe AI-powered ...
To the investigator and clinician, prostate-specific antigen (PSA) level is a seemingly perfect outcome measure because it is easily assessable, quantitative, reproducible, and inexpensive. Whether ...
CIRT leads to temporary urinary function decline, normalizing within three months and stable for five years. Prostate volume decreases significantly without ADT, remaining reduced for five years. T ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results